Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated
- PMID: 16565135
- PMCID: PMC1410834
- DOI: 10.1136/bmj.332.7543.727-a
Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated
Comment on
-
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.BMJ. 1988 Oct 15;297(6654):943-8. doi: 10.1136/bmj.297.6654.943. BMJ. 1988. PMID: 3142562 Free PMC article. Clinical Trial.
-
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.BMJ. 2006 Mar 25;332(7543):689-92. doi: 10.1136/bmj.38764.572569.7C. Epub 2006 Mar 3. BMJ. 2006. PMID: 16517548 Free PMC article. Clinical Trial.
References
-
- Miller AB. The costs and benefits of breast cancer screening. Am J Prev Med 1993;9: 175-80. - PubMed
-
- Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358: 1340-2. - PubMed
-
- Gøtzsche PC. On the benefits and harms of screening for breast cancer. Int J Epidemiol 2004;33: 56-64. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical